Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label TrialLynn R. Webster, Joseph Harper, Edward Michna et al.|Pain Medicine|2017Cited by 25
Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer painLynn R. Webster, Robert J. Israel|Journal of Pain Research|2018Cited by 12
Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadoneLynn R. Webster, Robert J. Israel|Journal of Pain Research|2018Cited by 7